Stay updated on Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T09:58:35.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T07:54:57.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as comprehensive drug information for various medications related to cancer treatment. Notably, the previous version's details on certain drugs and related topics have been removed.
    Difference
    4%
    Check dated 2025-08-31T01:03:47.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-16T19:17:28.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-09T15:01:41.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.6%
    Check dated 2025-08-02T13:59:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial page.